Solvias to Perform Release Testing on World’s First CRISPR-based Gene-Editing Therapy

Global Provider Signs Long-Term Agreement with Vertex Pharmaceuticals for CASGEVY™ KAISERAUGST, Switzerland, Jan. 23, 2024 /PRNewswire/ — Solvias, a global provider of chemistry, manufacturing, and control (CMC) analytics, announced today that it will perform analytical release testing…